Cadrenal Therapeutics, Inc.

New Filing
CIK: 0001937993·Biotechnology·DELAWARE·Filed: Apr 6, 2026
Total Offering

$7,923,235

Amount Sold

$7,923,235

Investors

1

First Sale

Apr 1, 2026

Offering Details

Type
Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2022
Non-Accredited Investors
No

Related Persons

NameRole
Quang X. Pham
Matthew Szot
James Ferguson
Jeffrey Cole
John R. Murphy
Steven Zelenkofske
Glynn Wilson
Lee Golden

Company

Cadrenal Therapeutics, Inc.

822 A1A NORTH, SUITE 306

PONTE VEDRA, FL, 32082

(904) 300-0701

SEC Filing

0001213900-26-040457

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free